A carregar...
Inherent Suppression of Thyroid Stimulating Hormone in Newly Diagnosed Dyslipidemic Patients – Indication for Use of Thyromimetics?
Background: Dyslipidemia triggers a sequel of metabolic derangements such as insulin resistance, hyperglycemia and oxidative stress via vicious cycle. Dyslipidemia is characterised by elevation of plasma cholesterol, triglycerides (TGs), or both, or a low level of high-density lipoprotein (HDL) whic...
Na minha lista:
| Publicado no: | J Clin Diagn Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
JCDR Research and Publications (P) Limited
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225880/ https://ncbi.nlm.nih.gov/pubmed/25386428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/10363.4905 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|